ArticleExperimental and therapeutic medicine2025
Association between flurbiprofen axetil use and operative complications occurring following colorectal surgery.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perioperative flurbiprofen axetil use and postoperative intestinal complications in elderly patients undergoing radical colorectal surgery.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the present study was to investigate the association between the perioperative use of flurbiprofen axetil and the incidence of intestinal complications in patients undergoing radical colorectal surgery. For this purpose, the present retrospective study collected the medical records of patients who underwent their first radical colorectal surgery at Peking University People's Hospital (Beijing, China) between January 2018 and March 2022. Data included patient demographics, surgical details, intraoperative drug administration and postoperative intestinal complications. Univariate and multivariate analyses were performed to identify the risk factors for intestinal complications. A total of 1,364 patients were analyzed, of whom 89 (6.5%) developed postoperative intestinal complications, including ileus (45 patients, 3.3%), anastomotic leakage (40 patients, 2.9%) and celiac fistula (9 patients, 0.7%). In total, 5 patients experienced two types of intestinal complications. Age [odds ratio (OR), 1.022; 95% confidence interval (CI), 1.002-1.042; P=0.028], perioperative use of flurbiprofen axetil (OR, 2.072; 95% CI, 1.223-3.508; P=0.007), duration of surgery >3 h (OR, 2.032; 95% CI, 1.181-3.496; P=0.010) and intraoperative consumption of opioids (OR, 1.012; 95% CI, 1.003-1.022; P=0.009) were independent risk factors for postoperative intestinal complications. Overall, the present study demonstrates that age, the perioperative use of flurbiprofen axetil, the duration of surgery >3 h and high intraoperative consumption of opioids may increase the risk of developing postoperative intestinal complications in patients undergoing radical colorectal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.